May 04, 2021: Teva Pharmaceutical Industries Ltd. announced the launch of its new Erythromycin tablets to treat or prevent a variety of bacterial infections.
February 27, 2020: GlaxoSmithKline plc (GSK) and Innoviva, Inc. announced the European Medicines Agency (EMA) approval of Trelegy Ellipta for the treatment of asthma in adults.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?